Vijay S. Suhag

Vijay S. Suhag

Hematology

8 Medical Plaza Drive
Suite 300
Roseville, CA 95661

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology

Published: April 11, 2024

Showing 1-1 of 1

Last Updated: 09/26/2026